148 related articles for article (PubMed ID: 33563536)
1. Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy.
Dimachkie MD; Bechtel MD; Robertson HL; Michel C; Lee EK; Sullivan DK; Chalise P; Thrasher JB; Parker WP; Godwin AK; Pathak HB; DiGiovanni J; Shivappa N; Hébert JR; Hamilton-Reeves JM
Urol Oncol; 2021 Aug; 39(8):495.e7-495.e15. PubMed ID: 33563536
[TBL] [Abstract][Full Text] [Related]
2. Phase II prospective randomized trial of weight loss prior to radical prostatectomy.
Henning SM; Galet C; Gollapudi K; Byrd JB; Liang P; Li Z; Grogan T; Elashoff D; Magyar CE; Said J; Cohen P; Aronson WJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):212-220. PubMed ID: 29203893
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of a Weight Management Program Tailored for Overweight Men with Localized Prostate Cancer - A Pilot Study.
Hamilton-Reeves JM; Johnson CN; Hand LK; Bechtel MD; Robertson HL; Michel C; Metcalf M; Chalise P; Mahan NJ; Mirza M; Lee EK; Sullivan DK; Klemp JR; Befort CA; Parker WP; Gibbs HD; Demark-Wahnefried W; Thrasher JB
Nutr Cancer; 2021; 73(11-12):2671-2686. PubMed ID: 33295204
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer.
Wilson RL; Shannon T; Calton E; Galvão DA; Taaffe DR; Hart NH; Lyons-Wall P; Newton RU
Surg Oncol; 2020 Dec; 35():182-188. PubMed ID: 32889251
[TBL] [Abstract][Full Text] [Related]
5. Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer.
Demark-Wahnefried W; Rais-Bahrami S; Desmond RA; Gordetsky JB; Hunter GR; Yang ES; Azrad M; Frugé AD; Tsuruta Y; Norian LA; Segal R; Grizzle WE
Br J Cancer; 2017 Oct; 117(9):1303-1313. PubMed ID: 28881355
[TBL] [Abstract][Full Text] [Related]
6. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
7. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy.
Bargão Santos P; Lobo J; Félix A; Silva F; Manso RT; Costa JO; Lourenço B; Sequeira JP; Jerónimo C; Patel HHR; Henrique R
Urol Oncol; 2020 Oct; 38(10):794.e17-794.e27. PubMed ID: 32278731
[TBL] [Abstract][Full Text] [Related]
8. Feasibility outcomes of a presurgical randomized controlled trial exploring the impact of caloric restriction and increased physical activity versus a wait-list control on tumor characteristics and circulating biomarkers in men electing prostatectomy for prostate cancer.
Demark-Wahnefried W; Nix JW; Hunter GR; Rais-Bahrami S; Desmond RA; Chacko B; Morrow CD; Azrad M; Frugé AD; Tsuruta Y; Ptacek T; Tully SA; Segal R; Grizzle WE
BMC Cancer; 2016 Feb; 16():61. PubMed ID: 26850040
[TBL] [Abstract][Full Text] [Related]
9. The Prostate Cancer Active Lifestyle Study (PALS): A randomized controlled trial of diet and exercise in overweight and obese men on active surveillance.
Wright JL; Schenk JM; Gulati R; Beatty SJ; VanDoren M; Lin DW; Porter MP; Morrissey C; Dash A; Gore JL; Etzioni R; Plymate SR; Neuhouser ML
Cancer; 2024 Jun; 130(12):2108-2119. PubMed ID: 38353455
[TBL] [Abstract][Full Text] [Related]
10. Impact of body mass index on biochemical recurrence rates after radical prostatectomy: an analysis utilizing propensity score matching.
Magheli A; Rais-Bahrami S; Trock BJ; Humphreys EB; Partin AW; Han M; Gonzalgo ML
Urology; 2008 Dec; 72(6):1246-51. PubMed ID: 18387658
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
[TBL] [Abstract][Full Text] [Related]
12. A study of caloric restriction versus standard diet in overweight men with newly diagnosed prostate cancer: a randomized controlled trial.
Wright JL; Plymate S; D'Oria-Cameron A; Bain C; Haugk K; Xiao L; Lin DW; Stanford JL; McTiernan A
Prostate; 2013 Sep; 73(12):1345-51. PubMed ID: 23775525
[TBL] [Abstract][Full Text] [Related]
13. Dietary Changes Impact the Gut Microbe Composition in Overweight and Obese Men with Prostate Cancer Undergoing Radical Prostatectomy.
Frugé AD; Ptacek T; Tsuruta Y; Morrow CD; Azrad M; Desmond RA; Hunter GR; Rais-Bahrami S; Demark-Wahnefried W
J Acad Nutr Diet; 2018 Apr; 118(4):714-723.e1. PubMed ID: 27988219
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1 and vascular endothelial growth factor as biomarkers for lymph node metastasis and poor cancer-specific survival in prostate cancer patients after radical prostatectomy.
Wang Q; Diao X; Sun J; Chen Z
Urol Oncol; 2013 Apr; 31(3):312-7. PubMed ID: 21367627
[TBL] [Abstract][Full Text] [Related]
15. Anthropometric differences in obese men with biochemical failure after radical retropubic prostatectomy.
Mucksavage P; Mitchell C; Kutikov A; Wein AJ; Torigian D; Malkowicz SB
Urol Oncol; 2012 Sep; 30(5):590-5. PubMed ID: 21396843
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).
Schenk JM; Neuhouser ML; Beatty SJ; VanDoren M; Lin DW; Porter M; Gore JL; Gulati R; Plymate SR; Wright JL
Contemp Clin Trials; 2019 Jun; 81():34-39. PubMed ID: 31002955
[TBL] [Abstract][Full Text] [Related]
17. Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.
Tomaszewski JJ; Chen YF; Bertolet M; Ristau BT; Woldemichael E; Nelson JB
Urology; 2013 May; 81(5):992-6. PubMed ID: 23453649
[TBL] [Abstract][Full Text] [Related]
18. Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomy.
Campeggi A; Xylinas E; Ploussard G; Ouzaid I; Fabre A; Allory Y; Vordos D; Abbou CC; Salomon L; de la Taille A
Urology; 2012 Sep; 80(3):576-84. PubMed ID: 22925233
[TBL] [Abstract][Full Text] [Related]
19. The effect of BMI on clinicopathologic and functional outcomes after open radical prostatectomy.
Mandel P; Kretschmer A; Chandrasekar T; Nguyen HG; Buchner A; Stief CG; Tilki D
Urol Oncol; 2014 Apr; 32(3):297-302. PubMed ID: 24332640
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
Moul JW
Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
